Max Robotics — Global Service Robot Directory + US Certification

About

Henrik Falconer is a prominent gynecologic oncologist whose research has fundamentally shaped the role of minimally invasive and robotic surgery in the treatment of gynecological cancers, particularly cervical and endometrial cancer. Based at a leading academic center in Sweden, Falconer has built an internationally recognized body of work focused on refining surgical staging, improving oncologic outcomes, and preserving fertility in women with early-stage cancers. His most-cited contribution, the SHREC trial (237 citations), established the diagnostic accuracy of sentinel lymph node algorithms in high-risk endometrial cancer, advancing a paradigm shift away from systematic lymphadenectomy. His leadership on the Robot-Assisted Approach to Cervical Cancer (RACC) randomized controlled trial (150 citations) and population-based cohort analyses have critically interrogated the safety of robotic radical hysterectomy, contributing essential evidence to ongoing surgical debates. His pioneering work on robot-assisted radical trachelectomy, spanning multiple international multicenter studies, has expanded fertility-sparing options for young women with cervical cancer. Beyond clinical research, Falconer helped develop European consensus standards for robotic surgical training through SERGS, shaping how the next generation of gynecologic surgeons is educated. With over 850 cumulative citations across his most influential papers, his work continues to define best practices in gynecologic oncology worldwide.